ISSN 1673-3770 CN 37-1437/R
JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (4): 15-21.doi: 10.6040/j.issn.1673-3770.0.2016.278
Previous Articles Next Articles
LI Yong
CLC Number:
| [1] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy [J]. J Allergy Clin Immunol, 2015, 136(3): 556-568. [2] Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper [J]. Allergy, 2014, 69(7): 854-867. [3] 中国过敏性鼻炎研究协作组. 过敏性鼻炎皮下免疫治疗专家共识2015 [J]. 中国耳鼻咽喉头颈外科, 2015, 22(8): 379-404. [4] Calderon M, Cardona V, Demoly P. One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions [J]. Allergy, 2012, 67(4): 462-476. [5] CMS update: desensitizing vaccines [J]. Br Med J, 1986, 293(6552): 984. [6] 宋薇薇, 林小平, 柴若楠, 等. 东北地区夏秋季花粉症患者变应原特异性免疫治疗的长期疗效 [J]. 中华临床免疫和变态反应杂志, 2012, 6(4): 266-271. SONG Weiwei, LIN Xiaoping, CHAI Ruonan, et al. Long-term efficacy of allergen specific immunotherapy for pollinosis patients in northeast china [J]. Chin J Allergy Clin Immunol, 2012, 6(4): 266-271. [7] 关凯, 魏庆宇, 尹佳. 葎草花粉变应原免疫治疗疗效和安全性评估 [J]. 中华临床免疫和变态反应杂志, 2012, 6(4): 279-284. GUAN Kai, WEI Qingyu, YIN Jia. Efficacy and safety of specific immunotherapy with Humulus Pollen extract[J]. Chin J Allergy Clin Immunol, 2012, 6(4): 279-284. [8] 叶世泰, 李美琏, 何海娟, 等. 过敏性鼻炎患者在特异性脱敏治疗中血清IgE的动态观察 [J]. 中华耳鼻咽喉科杂志, 1982, 17(2): 147-148. [9] 文昭明,叶世泰. 免疫疗法致不良反应的临床观察——附29例报告[J]. 中华微生物学和免疫学杂志, 2001(S2):68-71. [10] 张罗, 韩德民. 变应性鼻炎的变应原特异性皮下免疫治疗 [J]. 中华耳鼻咽喉头颈外科杂志, 2007, 42(9): 711-716. ZHANG Luo, HAN Demin. Allergen-specific subcutaneous immunotherapy for allergic rhinitis[J]. Chin J Otorhinolaryngol Head Neck Surg, 2007, 42(9):711-716. [11] 尹佳. 北京协和医院变应原制剂应用指南 [M]. 北京: 中国协和医科大学出版社, 2014. [12] Canonica G W, Baena-Cagnani C E, Bousquet J, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization(WAO)taskforce [J]. Allergy, 2007, 62(3): 317-324. [13] Rosner-Friese K, Kaul S, Vieths S, et al. Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs [J]. J Allergy Clin Immunol, 2015, 135(3): 636-643. [14] Brozek J L, Bousquet J, Baena-Cagnani C E, et al. Allergic Rhinitis and its Impact on Asthma(ARIA)guidelines: 2010 revision[J]. J Allergy Clin Immunol, 2010,126(3):466-476. [15] Canonica G W, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update[J]. World Allergy Organ J, 2014,7(1):6. [16] Wilson D R, Lima M T, Durham S R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis[J]. Allergy, 2005,60(1):4-12. [17] Pitsios C, Demoly P, Bilò M B, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper [J]. Allergy, 2015, 70(8): 897-909. [18] Casale T B, Stokes J R. Immunotherapy: what lies beyond [J]. J Allergy Clin Immunol, 2014, 133(3): 612-619: quiz 620. [19] von Moos S, Johansen P, Tay F, et al. Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy [J]. J Allergy Clin Immunol, 2014, 134(4): 965-967.e964. [20] Tabar A I, Echechipia S, Garcia BE, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus[J]. J Allergy Clin Immunol, 2005, 116(1): 109-118. [21] Temino V M, Wu P, Konig J, et al. Safety of multiple aeroallergen rush immunotherapy using a modified schedule [J]. Allergy Asthma Proc, 2013, 34(3): 255-260. [22] Rieker-Schwienbacher J, Nell M J, Diamant Z, et al. Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients [J]. Clin Transl Allergy, 2013, 3(1): 16. [23] Durham S R, Walker S M, Varga E M, et al. Long-term clinical efficacy of grass-pollen immunotherapy [J]. N Engl J Med, 1999, 341(7): 468-475. [24] Des Roches A, Paradis L, Knani J, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation, Allergy, 1996, 51(6): 430-433. [25] Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study [J]. J Allergy Clin Immunol, 2010, 126(5): 969-975. [26] Calderon M A, Cox L, Casale T B, et al. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence [J]. J Allergy Clin Immunol, 2012, 129(4): 929-934. [27] Calderon M A, Cox L S. Monoallergen sublingual immunotherapy versus multiallergen subcutaneous immunotherapy for allergic respiratory diseases: a debate during the AAAAI 2013 Annual Meeting in San Antonio, Texas [J]. J Allergy Clin Immunol Pract, 2014, 2(2): 136-143. [28] Nelson H S. Multiallergen immunotherapy for allergic rhinitis and asthma [J]. J Allergy Clin Immunol, 2009, 123(4): 763-769. [29] Amar S M, Harbeck R J, Sills M, et al. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract [J]. J Allergy Clin Immunol, 2009, 124(1): 150-156.e151-155. [30] Canonica G W, Bousquet J, Casale T, et al. Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009 [J]. Allergy, 2009, 64(Suppl 91): 1-59. [31] Kim J M, Lin S Y, Suarez-Cuervo C, et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review [J]. Pediatrics, 2013, 131(6):1155-1167. [32] Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update [J]. J Allergy Clin Immunol, 2011, 127(Suppl 1): S1-55. [33] Cox L S, Larenas Linnemann D, Nolte H, et al. Sublingual immunotherapy: a comprehensive review [J]. J Allergy Clin Immunol, 2006, 117(5): 1021-1035. [34] Makatsori M, Scadding G W, Lombardo C, et al. Dropouts in sublingual allergen immunotherapy trials-a systematic review [J]. Allergy, 2014, 69(5): 571-580. [35] Passalacqua G, Baena-Cagnani C E, Bousquet J, et al. Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language [J]. J Allergy Clin Immunol, 2013, 132(1): 93-98. [36] Cox L, Larenas-Linnemann D, Lockey R F, et al. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System [J]. J Allergy Clin Immunol, 2010, 125(3): 569-574, 574.e561-574.e567. [37] Coop C A, Tankersley M S. Patient perceptions regarding local reactions from allergen immunotherapy injections [J]. Ann Allergy Asthma Immunol, 2008, 101(1): 96-100. [38] Kelso J M. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction [J]. Ann Allergy Asthma Immunol, 2004, 92(2): 225-227. [39] Tankersley M S, Butler K K, Butler W K, et al. Local reactions during allergen immunotherapy do not require dose adjustment [J]. J Allergy Clin Immunol, 2000, 106(5): 840-843. [40] Roy S R, Sigmon J R, Olivier J, et al. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy [J]. Ann Allergy Asthma Immunol, 2007, 99(1): 82-86. [41] Epstein T G, Liss G M, Murphy-Berendts K, et al. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions [J]. J Allergy Clin Immunol Pract, 2014, 2(2): 161-167. [42] Bernstein D I, Epstein T, Murphy-Berendts K, et al. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study [J]. Ann Allergy Asthma Immunol, 2010, 104(6): 530-535. [43] Tinkelman D G, Cole W Q, 3rd Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions [J]. J Allergy Clin Immunol, 1995, 95(1 Pt 1): 8-14. [44] Cox L, Aaronson D, Casale T B, et al. Allergy immunotherapy safety: location matters [J]. J Allergy Clin Immunol Pract, 2013, 1(5): 455-457. [45] Calderon M A, Simons F E, Malling H J, et al. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile [J]. Allergy, 2012, 67(3): 302-311. [46] de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet [J]. Allergy, 2009, 64(6): 963-964. [47] Miehlke S, Alpan O, Schroder S, et al. Induction of eosinophilic esophagitis by sublingual pollen immunotherapy [J]. Case Rep Gastroenterol, 2013, 7(3): 363-368. [48] HollisterStier Allergy, Allergenic extracts in bulk vial. Available at: http://www.hsallergy.com/products_ordering/product_inserts.aspx. In, May 11, 2013. |
| [1] | LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28. |
| [2] | GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111. |
| [3] | QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77. |
| [4] | DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86. |
| [5] | XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167. |
| [6] | XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33. |
| [7] | HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41. |
| [8] | LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48. |
| [9] | ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147. |
| [10] | ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134. |
| [11] | LIU Chang, YANG Jingpu, GAO Yu, WANG Wenjia. Analysis of allergen detection results in children with allergic rhinitis in the Changchun area [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 51-58. |
| [12] | ZHOU Heqing, SHEN Qi. Research progress on biomarkers of traditional Chinese medicine in the treatment of allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 168-176. |
| [13] | WANG Manxian, ZHENG Quan, YANG Liang. Research progress in the treatment of allergic rhinitis with bacterial lysates [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 141-145. |
| [14] | LIU Chang, FANG Hongyan, LIU Xiao, FU Dongna, WANG He, WANG Jing, YANG Jingpu. Analysis of sensitization characteristics of Artemisia pollen in autumn allergic rhinitis in the Changchun area of China [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 13-19. |
| [15] | ZHANG Jie, CHEN Min, SHEN Zhengzheng, WU Yuhua, LIU Yuanhu, SUN Hao, TAN Xinhua, NI Shuren, YANG Shuxun, SHI Xuezheng, NI Xin. Study on the correlation between allergic rhinitis and coronavirus disease-2019 infection and symptoms in children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 36-42. |
|
||